Close Menu
Home › Foundation Medicine Q3 Revenues Rise 16 Percent, Net Loss Widens

Foundation Medicine Q3 Revenues Rise 16 Percent, Net Loss Widens

Nov 02, 2016
|
staff reporter

This article has been updated with information and comments from Foundation Medicine's earnings conference call.

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that third quarter revenues rose 16 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Cancer

  1. Employee Benefits Programs Share Early Experiences Implementing Genetic Testing

    Premium

  2. HTG Molecular Diagnostics Files for $20M Stock Offering

  3. FDA Clears NantHealth Tumor-Normal Whole-Exome Test

  4. AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

    Premium

  5. Exact Sciences Sues Johns Hopkins University for 'Improperly' Demanding Royalties

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.